Gilpin Sarah E, Ren Xi, Okamoto Tatsuya, Guyette Jacques P, Mou Hongmei, Rajagopal Jayaraj, Mathisen Douglas J, Vacanti Joseph P, Ott Harald C
Department of Surgery, Massachusetts General Hospital, and Harvard Medical School, Boston, Massachusetts.
Department of Surgery, Massachusetts General Hospital, and Harvard Medical School, Boston, Massachusetts.
Ann Thorac Surg. 2014 Nov;98(5):1721-9; discussion 1729. doi: 10.1016/j.athoracsur.2014.05.080. Epub 2014 Aug 19.
Whole-lung scaffolds can be created by perfusion decellularization of cadaveric donor lungs. The resulting matrices can then be recellularized to regenerate functional organs. This study evaluated the capacity of acellular lung scaffolds to support recellularization with lung progenitors derived from human induced pluripotent stem cells (iPSCs).
Whole rat and human lungs were decellularized by constant-pressure perfusion with 0.1% sodium dodecyl sulfate solution. Resulting lung scaffolds were cryosectioned into slices or left intact. Human iPSCs were differentiated to definitive endoderm, anteriorized to a foregut fate, and then ventralized to a population expressing NK2 homeobox 1 (Nkx2.1). Cells were seeded onto slices and whole lungs, which were maintained under constant perfusion biomimetic culture. Lineage specification was assessed by quantitative polymerase chain reaction and immunofluorescent staining. Regenerated left lungs were transplanted in an orthotopic position.
Activin-A treatment, followed by transforming growth factor-β inhibition, induced differentiation of human iPSCs to anterior foregut endoderm as confirmed by forkhead box protein A2 (FOXA2), SRY (Sex Determining Region Y)-Box 17 (SOX17), and SOX2 expression. Cells cultured on decellularized lung slices demonstrated proliferation and lineage commitment after 5 days. Cells expressing Nkx2.1 were identified at 40% to 60% efficiency. Within whole-lung scaffolds and under perfusion culture, cells further upregulated Nkx2.1 expression. After orthotopic transplantation, grafts were perfused and ventilated by host vasculature and airways.
Decellularized lung matrix supports the culture and lineage commitment of human iPSC-derived lung progenitor cells. Whole-organ scaffolds and biomimetic culture enable coseeding of iPSC-derived endothelial and epithelial progenitors and enhance early lung fate. Orthotopic transplantation may enable further in vivo graft maturation.
全肺支架可通过对尸体供肺进行灌注脱细胞处理来构建。然后,所得的基质可重新细胞化以再生功能性器官。本研究评估了脱细胞肺支架支持由人诱导多能干细胞(iPSC)来源的肺祖细胞重新细胞化的能力。
用0.1%十二烷基硫酸钠溶液恒压灌注对大鼠和人全肺进行脱细胞处理。将所得的肺支架制成冰冻切片或保持完整。将人iPSC分化为确定内胚层,向前肠命运诱导,然后向腹侧诱导为表达NK2同源盒1(Nkx2.1)的细胞群体。将细胞接种到切片和全肺上,在恒压灌注仿生培养条件下进行培养。通过定量聚合酶链反应和免疫荧光染色评估谱系特化。将再生的左肺原位移植。
经激活素A处理,随后抑制转化生长因子-β,可诱导人iPSC分化为前肠内胚层,叉头框蛋白A2(FOXA2)、SRY(性别决定区Y)-盒17(SOX17)和SOX2表达可证实这一点。在脱细胞肺切片上培养的细胞在5天后表现出增殖和谱系定向。以40%至60%的效率鉴定出表达Nkx2.1的细胞。在全肺支架内并在灌注培养条件下,细胞进一步上调Nkx2.1表达。原位移植后,移植物由宿主血管和气道进行灌注和通气。
脱细胞肺基质支持人iPSC来源的肺祖细胞的培养和谱系定向。全器官支架和仿生培养能够共同接种iPSC来源的内皮祖细胞和上皮祖细胞,并增强早期肺命运。原位移植可能使移植物在体内进一步成熟。